World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
92
Citations
45180
World Ranking
607
National Ranking
279

Medicine

D-Index
94
Citations
46167
World Ranking
10285
National Ranking
5288

John H. Rex publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where John H. Rex sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 233 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

John H. Rex D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where John H. Rex sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 92 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

John H. Rex is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily focuses on fields related to medicine, with a significant body of work in infectious diseases, economics and econometrics, applied microbiology and biotechnology, epidemiology, and pharmacology.

Their publication record includes contributions to multiple prominent venues, highlighting a consistent focus on infectious disease and antimicrobial topics. Frequent publication venues encompass Open Forum Infectious Diseases, Clinical Infectious Diseases, Antimicrobial Agents and Chemotherapy, Translational Research, and Nature Reviews Microbiology.

Key topics covered in John H. Rex's research include:

  • Antifungal resistance and susceptibility
  • Antibiotic Use and Resistance
  • Pharmaceutical Economics and Policy
  • Fungal Infections and Studies
  • Antibiotic Resistance in Bacteria
  • Infectious Diseases and Mycology
  • Pharmaceutical industry and healthcare

Among their recent papers, notable titles include:

  • "Critical analysis of antibacterial agents in clinical development" (2020), published in Nature Reviews Microbiology
  • "Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010-2020" (2021), published in Clinical Infectious Diseases
  • "In Vivo Efficacy of Olorofim against Systemic Scedosporiosis and Lomentosporiosis" (2021), published in Antimicrobial Agents and Chemotherapy
  • "Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization" (2020), published in Translational Research
  • "Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?" (2021), published in Value in Health

John H. Rex collaborates frequently with several researchers, including Kevin Outterson, Johan Maertens, Karen Cornelissen, Aaron Dane, and Daniela Zinzi. These coauthors appear repeatedly in multiple research efforts, indicating ongoing scientific partnerships.

Best Publications

  • Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

    Peter G. Pappas;Carol A. Kauffman;David Andes;Daniel K. Benjamin

  • Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

    S. Ascioglu;J. H. Rex;B. De Pauw;J. E. Bennett

  • Guidelines for Treatment of Candidiasis

    Peter G. Pappas;John H. Rex;Jack D. Sobel;Scott G. Filler

  • Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections

    John H. Rex;Michael A. Pfaller;John N. Galgiani;Marilyn S. Bartlett

  • Practice Guidelines for the Treatment of Candidiasis

    John H. Rex;Thomas J. Walsh;Jack D. Sobel;Scott G. Filler

  • A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

    John H. Rex;John E. Bennett;Alan M. Sugar;Peter G. Pappas

  • RESISTANCE OF CANDIDA SPECIES TO FLUCONAZOLE

    J H Rex;M G Rinaldi;M A Pfaller

  • A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

    Peter G. Pappas;John H. Rex;Jeannette Lee;Richard J. Hamill

  • Alternatives to antibiotics—a pipeline portfolio review

    Lloyd Czaplewski;Richard Bax;Martha Clokie;Mike Dawson

  • Multicenter Clinical Evaluation of the (1→3) β-D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans

    Luis Ostrosky-Zeichner;Barbara D. Alexander;Daniel H. Kett;Jose Antonio Vazquez

  • Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials

    David R. Andes;Nasia Safdar;John W. Baddley;Geoffrey Playford

  • β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

    Zekaver Odabasi;Gloria Mattiuzzi;Elihu Estey;Hagop Kantarjian

  • Combating antimicrobial resistance: policy recommendations to save lives.

    Spellberg B;Blaser M;Guidos Rj

  • A Randomized and Blinded Multicenter Trial of High-Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects

    John H. Rex;John H. Rex;Peter G. Pappas;Adolf W. Karchmer;Jack Sobel

  • Combination Antifungal Therapy

    Melissa D. Johnson;Conan MacDougall;Luis Ostrosky-Zeichner;John R. Perfect

  • Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

    Luis Ostrosky-Zeichner;John H. Rex;Peter G. Pappas;Richard J. Hamill

  • Antifungal Susceptibility Testing: Practical Aspects and Current Challenges

    John H. Rex;Michael A. Pfaller;Thomas J. Walsh;Vishnu Chaturvedi

  • Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

    B J Kullberg;J D Sobel;M Ruhnke;P G Pappas

  • An insight into the antifungal pipeline: selected new molecules and beyond.

    Luis Ostrosky-Zeichner;Arturo Casadevall;John N. Galgiani;Frank C. Odds

  • Amphotericin B: Time for a New “Gold Standard”

    Luis Ostrosky-Zeichner;Kieren A Marr;John H Rex;John H Rex;Stuart H Cohen

  • Antifungal drug resistance in pathogenic fungi.

    H Vanden Bossche;F Dromer;I Improvisi;M Lozano-Chiu

Frequent Co-Authors

Luis Ostrosky-Zeichner
Luis Ostrosky-Zeichner The University of Texas Health Science Center at Houston
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
Peter G. Pappas
Peter G. Pappas University of Alabama at Birmingham
Michael A. Pfaller
Michael A. Pfaller JMI Laboratories
Jack D. Sobel
Jack D. Sobel Wayne State University
John E. Bennett
John E. Bennett National Institutes of Health
John E. Edwards
John E. Edwards University of California, Los Angeles
Elias Anaissie
Elias Anaissie University of Cincinnati
Michael G. Rinaldi
Michael G. Rinaldi The University of Texas Health Science Center at San Antonio
Mahmoud A. Ghannoum
Mahmoud A. Ghannoum Case Western Reserve University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students exploring microbiology, expanding your skill set with complementary healthcare qualifications can open diverse career opportunities. For example, becoming a certified professional coder (cpc) offers a specialized path within medical records and billing, combining technical knowledge with healthcare expertise.

Healthcare organizations increasingly rely on efficient data management, making a role in health information leadership promising. Exploring the healthcare information management salary landscape reveals strong demand and competitive compensation for experts who blend clinical understanding with management skills.

Accredited programs are crucial for credibility and career advancement. Pursuing an accredited online health information management degree cahiim ensures you receive quality education aligned with industry standards, preparing you for certification and leadership roles.

For those seeking quick entry into the field, an online medical billing and coding certificate fast can accelerate your qualification timeline, enabling you to start your career efficiently while building a strong foundation in healthcare administration.

Best Scientists Citing John H. Rex

Trending Scientists